Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25671254

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2015 Feb 12
First author
Schlumberger M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Apr;12(4):189. doi: 10.1038/nrclinonc.2015.30.
    note
    Source null
    related pmid
    25707627
    relationship
    Comment in
  2. citation
    Nat Rev Endocrinol. 2015 Jun;11(6):325-7. doi: 10.1038/nrendo.2015.53.
    note
    Source null
    related pmid
    25824678
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 May 7;372(19):1868. doi: 10.1056/NEJMc1503150.
    note
    Source null
    related pmid
    25946295
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 May 7;372(19):1868. doi: 10.1056/NEJMc1503150.
    note
    Source null
    related pmid
    25946296
    relationship
    Comment in

Authors and identifiers

  1. name
    Schlumberger M
    type
    Author
  2. name
    Tahara M
    type
    Author
  3. name
    Wirth LJ
    type
    Author
  4. name
    Robinson B
    type
    Author
  5. name
    Brose MS
    type
    Author
  6. name
    Elisei R
    type
    Author
  7. name
    Habra MA
    type
    Author
  8. name
    Newbold K
    type
    Author
  9. name
    Shah MH
    type
    Author
  10. name
    Hoff AO
    type
    Author
  11. name
    Gianoukakis AG
    type
    Author
  12. name
    Kiyota N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Schlumberger M
    type
    Author
  2. name
    Tahara M
    type
    Author
  3. name
    Wirth LJ
    type
    Author
  4. name
    Robinson B
    type
    Author
  5. name
    Brose MS
    type
    Author
  6. name
    Elisei R
    type
    Author
  7. name
    Habra MA
    type
    Author
  8. name
    Newbold K
    type
    Author
  9. name
    Shah MH
    type
    Author
  10. name
    Hoff AO
    type
    Author
  11. name
    Gianoukakis AG
    type
    Author
  12. name
    Kiyota N
    type
    Author
bibliography ids
  1. nci-bib-75814fcc5991949af00f241e
book metadata
content sha256
4268b7a44f4a5cedb2bbea737bb7b1dffcffdc5526fa206e8409fa2ed2904572
document type
citation
dois
  1. 10.1056/NEJMoa1406470
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:25671254
immutable id
pubmed:25671254@4268b7a44f4a5cedb2bbea737bb7b1dffcffdc5526fa206e8409fa2ed2904572
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
7
name
The New England journal of medicine
nlm unique id
0255562
pages
621-30
volume
372
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Apr;12(4):189. doi: 10.1038/nrclinonc.2015.30.
    note
    Source null
    related pmid
    25707627
    relationship
    Comment in
  2. citation
    Nat Rev Endocrinol. 2015 Jun;11(6):325-7. doi: 10.1038/nrendo.2015.53.
    note
    Source null
    related pmid
    25824678
    relationship
    Comment in
  3. citation
    N Engl J Med. 2015 May 7;372(19):1868. doi: 10.1056/NEJMc1503150.
    note
    Source null
    related pmid
    25946295
    relationship
    Comment in
  4. citation
    N Engl J Med. 2015 May 7;372(19):1868. doi: 10.1056/NEJMc1503150.
    note
    Source null
    related pmid
    25946296
    relationship
    Comment in
outcomes validated
false
pmid
25671254
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
47caa30b2b6cf3c0a852ec5adc0b8634823e7850c5c1b06a705d06e72f2d0519
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Feb 12
precision
day
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25671254/
title
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Preserved source evidence · Not medical advice